- Lisa Green
On Friday I attended the Molecular Medicine Tri-Conference held in San Francisco. It was an exciting day of talks including the announcement of the transfer of a large amount of Merck data into the public domain through the new non-profit entity, Sage.
Many of the conference talks addressed the problem of accessing and connecting massive amounts of biological data, including the talk given by my colleague, NextBio cofounder Ilya Kupershmidt. I’ll readily admit I am biased – I think Ilya is the bee’s knees – but I thought Ilya did an exceptional job addressing these issues. He detailed the challenges of effectively leveraging the ever-increasing collection of biological data in a clear and logical manner and then went on to present a compelling approach.
While the last day of a conference generally tends to be fairly low energy, Ilya’s talk created an audible buzz and several enthusiastic conversations. It could be that the vaguely coffee-flavored beverage served by the conference center was actually some kind of GMO supercoffee, but my bet is that the energy was brewed up by Ilya’s talk.*